| David Kishbaugh, DO | |
|
2109 Valleygate Dr, Suite 201, Fayetteville, NC 28304-3571 | |
| (910) 486-8880 | |
| (910) 486-8886 |
| Full Name | David Kishbaugh |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 41 Years |
| Location | 2109 Valleygate Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053374157 | NPI | - | NPPES |
| 8949528 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 9500379 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rpk Center For Rehab, Spine And Pain | 0749279438 | 5 |
News Archive
A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis.
Relapse is a common feature of addiction recovery – two in three patients treated for substance use disorder in the United States relapse within 12 months, according to the Journal of the American Medical Association.
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
The prospect of creating artery "banks" available for cardiovascular surgery, bypassing the need to harvest vessels from the patient, could transform treatment of many common heart and vascular ailments.
› Verified 1 days ago
| Entity Name | Rpk Center For Rehab, Spine & Pain |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093778110 PECOS PAC ID: 0749279438 Enrollment ID: O20040507001264 |
News Archive
A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis.
Relapse is a common feature of addiction recovery – two in three patients treated for substance use disorder in the United States relapse within 12 months, according to the Journal of the American Medical Association.
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
The prospect of creating artery "banks" available for cardiovascular surgery, bypassing the need to harvest vessels from the patient, could transform treatment of many common heart and vascular ailments.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Kishbaugh, DO Po Box 41054, Fayetteville, NC 28309-1054 Ph: (910) 486-8880 | David Kishbaugh, DO 2109 Valleygate Dr, Suite 201, Fayetteville, NC 28304-3571 Ph: (910) 486-8880 |
News Archive
A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis.
Relapse is a common feature of addiction recovery – two in three patients treated for substance use disorder in the United States relapse within 12 months, according to the Journal of the American Medical Association.
KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.
The prospect of creating artery "banks" available for cardiovascular surgery, bypassing the need to harvest vessels from the patient, could transform treatment of many common heart and vascular ailments.
› Verified 1 days ago
Cassidi Michelle Benavidez, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2919 Breezewood Ave Ste 101, Fayetteville, NC 28303 Phone: 910-484-1711 | |
Dr. Zane T Walsh Jr., M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2930 Village Dr, Fayetteville, NC 28304 Phone: 910-323-9010 Fax: 910-829-9530 | |
Judit Andrea Cope, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4140 Ferncreek Dr Ste 801, Fayetteville, NC 28314 Phone: 910-484-2171 Fax: 910-484-4568 | |
Felicia Stakely, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1700 Pamalee Dr, Fayetteville, NC 28301 Phone: 910-488-2295 | |
Dr. James Wesley Williams, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2300 Ramsey St, Fayetteville, NC 28301 Phone: 910-482-5202 | |
Caroline Miller Harris, PA-C Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1540 Purdue Dr Ste 200, Fayetteville, NC 28303 Phone: 910-630-1112 Fax: 910-425-1110 |